PetMed Express, Inc. (PETS)

22.31
NASDAQ
Prev Close 22.31
Day Low/High 0.00 / 0.00
52 Wk Low/High 20.25 / 46.83
Exchange NASDAQ
Shares Outstanding 20.67B
Market Cap 461.24M
Div & Yield N.A. (N.A)
Noteworthy Thursday Option Activity: PETS, CENX, TVPT

Noteworthy Thursday Option Activity: PETS, CENX, TVPT

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in PetMed Express Inc , where a total of 711 contracts have traded so far, representing approximately 71,100 underlying shares. That amounts to about 47.5% of PETS's average daily trading volume over the past month of 149,835 shares.

PetMed Express Is a Model of Consistency

Upcoming earnings could be the catalyst for a PETS move higher.

Trifecta Stocks Weekly Roundup

While we didn't add any new names this week, we did use recent weakness in AT&T shares to build that position further.

September Retail and Food Services Sales Are Up

An analysis of the data and what it means for the portfolio.

Trifecta Stocks Weekly Roundup

In the first week of the fourth quarter we continued our strategy of using stock-specific weakness to grow positions while improving our cost basis by adding to 2 names.

Trifecta Stocks Weekly Roundup

As we close out September and the third quarter we have ample 'fire power' to continue improving the cost basis of current holdings and initiate new positions.

Trifecta Stocks Weekly Roundup

The model portfolio had a number of strong performers this week as the market welcomed the Fed's lack of action with open arms.

Scaling Into Four Current Positions

It's time to put this incremental cash to work.

PetMed Express Is a Safe Play in a Storm

The stock has held firm above support.

Trifecta Stocks Weekly Roundup

Most of the portfolio got caught in this week's downdraft, though we used weakness to add to our position in Sherwin-Williams.

Trifecta Stocks Weekly Roundup

We added no positions this week, although we scaled up our position sizes in both Costco Wholesale and United Parcel Service.

Trifecta Stocks Weekly Roundup

We eliminated our position in Fortive but bulked up our stakes in recent newbies Sherwin-Williams and Whirlpool and added Nike to the portfolio.

This Could Be a Good Time to Get More PetMed

The bull flag is ideal for those who want to increase their position.

Trifecta Stocks Weekly Roundup

This week Whirlpool jumped into the portfolio pool, where it joined recent additions Sherwin-Williams and International Flavors & Fragrances.

Trifecta Stocks Weekly Roundup

This week we promoted International Flavors & Fragrances from the Bullpen and added it to our active portfolio, where it joined recent newbie Sherwin-Williams.

Pets Are Big Business Now and These Stocks Are Behind the Trend

Pets Are Big Business Now and These Stocks Are Behind the Trend

TheStreet's Jim Cramer says the humanization of pets is a growing investment opportunity.

Pets Are Family Now and These Stocks Are Best in Show

Pets Are Family Now and These Stocks Are Best in Show

The humanization of pets has sent spending soaring, which has some pet-related stock seeing major benefits.

Trifecta Stocks Weekly Roundup

We welcomed paint maker Sherwin-Williams into the Trifecta portfolio fold this week.

PETS Ex-Dividend Reminder - 8/4/16

PETS Ex-Dividend Reminder - 8/4/16

Looking at the universe of stocks we cover at Dividend Channel, on 8/4/16, PetMed Express Inc will trade ex-dividend, for its quarterly dividend of $0.19, payable on 8/19/16. As a percentage of PETS's recent stock price of $20.85, this dividend works out to approximately 0.91%, so look for shares of PetMed Express Inc to trade 0.91% lower — all else being equal — when PETS shares open for trading on 8/4/16.

Trifecta Stocks Weekly Roundup

Favorable results from Alphabet and PetMed Express led us to raise our price targets on those stocks.

PetMed's Chart Has Reached Animal Spirits

PETS has been a winner for the portfolio and a pullback would set up a nice buying opportunity.

Take Profits in PetMed, Then Wait for a Pullback

Take Profits in PetMed, Then Wait for a Pullback

At best, the stock should be priced at around $18, or 12% lower.

PetMed Reports a Tail-Thumping Bottom-Line Beat

We suspect Wall Street will be boosting its expectations for the back half of 2016.

Trifecta Stocks Weekly Roundup

In a week that saw the market continue to rise and several strong performers in the portfolio, we exited one position and trimmed another.

Jim Cramer's Top Takeaways: Zoetis, Idexx, Danaher, Fortive

Jim Cramer's Top Takeaways: Zoetis, Idexx, Danaher, Fortive

Cramer is faithful to pet care drug maker Zoetis and he prefers Danaher over its split-off sibling Fortive.

Jim Cramer's 'Mad Money' Recap: Why Some Stocks Pass Earnings Test and Others Fail

Jim Cramer's 'Mad Money' Recap: Why Some Stocks Pass Earnings Test and Others Fail

Johnson & Johnson was easy, Cramer says, but other stocks were more problematic.

Trifecta Stocks Weekly Roundup

Most of our portfolio names did well, though we did downgrade AT&T and Costco to Twos from Ones because of the moves higher in their shares in recent weeks.

TheStreet Quant Rating: C+ (Hold)